Lisata Therapeutics

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$1,000
$0
$0
$0
Gross Profit
91
-45
-46
EBITDA
-4,908
-5,294
-5,478
-6,555
EBIT
-4,775
-5,336
-5,523
-6,601
Net Income
-4,610
-4,930
-5,044
-5,401
Net Change In Cash
1,000
0
0
0
Free Cash Flow
-4,528
-2,518
-5,283
-7,027
Cash
16,209
19,509
28,293
21,805
Basic Shares
8,329
8,321
8,308
8,294

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$1,000
$0
$121,372
$0
Gross Profit
1,000
-189
63,771
-55
EBITDA
-22,235
-25,519
-115,202
-28,995
EBIT
-22,409
-25,708
-115,271
-29,050
Net Income
-19,985
-20,840
-54,225
-27,466
Net Change In Cash
1,000
0
121,372
0
Free Cash Flow
-19,356
-20,032
-21,455
-22,305
Cash
16,209
22,593
32,154
24,647
Basic Shares
8,329
8,073
5,180
3,687

Earnings Calls

Quarter EPS
2024-12-31
-$0.55
2024-09-30
-$0.59
2024-06-30
-$0.61
2024-03-31
-$0.65